EXACT Therapeutics Feed

2026-09-04 13:38:17 EXTX: EXACT Therapeutics publishes shareholder information regarding the delisting 0,77 NOK | -1,92% | 0,00 MNOK

2026-09-03 13:41:15 EXTX: EXACT Therapeutics first half 2026 interim report 0,78 NOK | +6,85% | 0,03 MNOK

2026-08-31 08:55:57 EXACT Therapeutics AS - Issuance of share options 0,77 NOK | +10,79% | 0,02 MNOK

2026-06-30 14:24:30 EXACT Therapeutics AS - Removal from trading 0,81 NOK | +1,87% | 0,05 MNOK

2026-06-30 14:24:30 EXACT Therapeutics AS - Strykning 0,81 NOK | +1,87% | 0,05 MNOK

2026-06-26 08:10:06 EXACT Therapeutics: Positive second safety read-out from the Phase 2 ENACT trial in pancreatic cancer 0,80 NOK | +4,58% | 0,03 MNOK

2026-06-17 15:31:10 EXTX: Received application for delisting 0,75 NOK | -6,25% | 0,03 MNOK

2026-06-17 15:31:10 EXTX: Mottatt søknad om strykning 0,75 NOK | -6,25% | 0,03 MNOK

2026-06-04 09:00:00 EXACT Therapeutics - webcast presentation 0,75 NOK | -13,29% | 0,37 MNOK

2026-06-01 17:05:12 EXACT Therapeutics: Announces webcast regarding strategic intent to delist the company's shares from listing on Euronext Growth, Oslo 0,71 NOK | +7,58% | 0,06 MNOK

2026-05-29 09:09:46 EXACT Therapeutics - Notice for Annual General Meeting 2026 0,87 NOK | -35,56% | 0,61 MNOK

2026-05-29 09:09:18 EXACT Therapeutics: Strategic intent to delist the company's shares from listing on Euronext Growth, Oslo 0,87 NOK | -35,56% | 0,61 MNOK

2026-04-09 07:14:29 EXACT Therapeutics - Annual Report 2025 1,63 NOK | -0,61% | 0,01 MNOK

2026-03-26 12:00:30 EXACT Therapeutics AS: Share capital increase registered 1,90 NOK | -8,65% | 0,24 MNOK

2026-03-13 16:28:53 EXACT Therapeutics AS - Minutes from extraordinary general meeting on 13 March 2026 2,20 NOK | +20,22% | 0,03 MNOK

2026-03-03 14:15:59 EXACT Therapeutics - First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer 1,87 NOK | +10,00% | 0,01 MNOK

2026-02-27 13:16:31 EXACT Therapeutics AS: Notice of extraordinary general meeting 1,70 NOK | +2,41% | 0,02 MNOK

2026-02-27 08:54:50 EXACT Therapeutics AS: Warrants exercise 1,70 NOK | +2,41% | 0,02 MNOK

2026-02-12 10:48:33 EXTX: Financial calendar

2026-02-11 08:00:00 EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program 1,95 NOK | +3,72% | 0,00 MNOK

2026-02-06 08:30:00 EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program 1,88 NOK | -1,05% | 0,02 MNOK

2026-02-05 13:19:14 EXACT Therapeutics: Correction of final warrants exercise date

2026-02-05 10:53:16 EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

2026-02-05 09:17:16 EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders

2026-02-05 08:30:31 EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

2026-01-27 08:00:08 EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants 1,75 NOK | -6,42% | 0,09 MNOK

2026-01-08 08:30:00 EXTX: EXACT Therapeutics' Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium 2,18 NOK | +45,33% | 0,12 MNOK

2025-11-25 12:57:41 EXTX: EXACT Therapeutics to present company update 1,52 NOK | -20,00% | 0,01 MNOK

2025-11-24 08:25:02 EXACT Therapeutics AS: New option program and receipt of share options by primary insiders 1,90 NOK | -5,00% | 0,00 MNOK

2025-09-25 08:00:00 EXTX: EXACT Therapeutics first half 2025 interim results 2,00 NOK | +5,26% | 0,20 MNOK

2025-09-18 08:00:00 EXTX: EXACT Therapeutics' Phase 2 trial to be presented at the 2025 AACR Special Conference 2,20 NOK | -1,79% | 0,00 MNOK

2025-09-09 08:00:00 EXTX: EXACT Therapeutic's Acoustic Cluster Therapy to be presented at the Ninth International Cancer lmmunotherapy Conference 2,24 NOK | 0,00% | 0,05 MNOK

2025-08-12 08:30:00 EXTX: EXACT Therapeutics to Present at the European Society for Medical Oncology (ESMO) Congress 2025

2025-08-11 11:08:28 EXTX: Financial calendar 2,76 NOK | +2,99% | 0,02 MNOK

2025-07-08 08:30:00 EXTX: EXACT Therapeutics announces grant of core patent in the U.S. 2,80 NOK | -0,71% | 0,02 MNOK

2025-06-24 08:00:00 EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer 2,70 NOK | -3,57% | 0,19 MNOK

2025-06-24 08:00:00 EXTX: EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer 2,70 NOK | -3,57% | 0,19 MNOK

2025-06-13 12:09:49 EXACT Therapeutics AS: Primary insider notification 2,96 NOK | +13,85% | 0,01 MNOK

2025-06-13 12:05:27 EXTX: EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 2,96 NOK | +13,85% | 0,01 MNOK

2025-06-04 09:20:37 EXACT Therapeutics AS - Information regarding voting at the Annual General Meeting 2025 2,70 NOK | +4,65% | 0,10 MNOK

2025-05-28 14:53:38 EXACT Therapeutics AS - Notice of Annual General Meeting 2025 2,98 NOK | +7,19% | 0,00 MNOK

2025-05-20 08:30:00 EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer 2,94 NOK | -2,00% | 0,61 MNOK

2025-05-20 08:30:00 EXTX: EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer 2,94 NOK | -2,00% | 0,61 MNOK

2025-05-14 08:35:45 EXTX: EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain 3,10 NOK | +13,97% | 0,01 MNOK

2025-05-07 10:47:40 EXTX: EXACT Therapeutics announces grant of key patent in Japan 2,80 NOK | -6,67% | 0,25 MNOK

2025-04-09 21:17:44 EXACT Therapeutics - 2024 Annual Report

2025-01-28 08:00:00 EXTX: EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model 3,50 NOK | +8,70% | 0,28 MNOK

2025-01-07 11:58:03 EXTX: Financial calendar 3,40 NOK | -1,73% | 0,25 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode